About Otsuka
Business Collaborators
Central Nervous System
H. Lundbeck A/S (Denmark)

- Joint development and commercialization of ABILIFY Maintena and REXULTI / RXULTI
- Joint development and commercialization of Selincro in Japan
Teva Pharmaceutical Industries, Ltd. (Israel)

- Development and commercialization of AJOVY in Japan
UCB S.A. (Belgium), UCB Japan

- Development and commercialization of NEUPRO Patch in Japan
Sumitomo Pharma Co., Ltd. (Japan)

- Development, manufacture and commercialization of ulotaront (SEP-363856) and SEP-380135 worldwide
Click Therapeutics, Inc. (U.S.)

- Collaboration on development and commercialization of digital therapeutic application Rejoyn
Perception Neuroscience, Inc. (U.S.)

- Development and commercialization of R-ketamine in Japan
Jolly Good Inc. (Japan)

- Joint development and commercialization of the social skills training platform using virtual reality in Japan
Ai-BrainScience Inc. (Japan)

- Sales collaboration on the cognitive function testing application that uses Eye Tracking technology
Oncology
Takeda Pharmaceutical Company Limited (Japan)

- Joint development and commercialization of Iclusig in ten Asian countries and regions including Japan
Pierre Fabre (France)

- Business related to Busulfex in European and South American countries
Illumina, Inc. (U.S.)

- Development and commercialization of IVD test kit for patients in Japan with blood cancer
Cardiovascular and Renal
Novartis Pharma K.K.
(Japanese subsidiary of parent company in Switzerland)
(Japanese subsidiary of parent company in Switzerland)

- Co-promotion of Entresto in Japan
Esperion Therapeutics, Inc. (U.S.)

- Development and commercialization of bempedoic acid in Japan
Aurinia Pharmaceuticals, Inc. (Canada & U.S.)

- Development and commercialization of voclosporin in Japan and Europe
Rare Diseases
Ionis Pharmaceuticals, Inc. (U.S.)

- Development and commercialization of donidalorsen in Europe and the Asia-Pacific region including Japan
Gastroenterology
Takeda Pharmaceutical Company Limited (Japan)

- Co-promotion of Takecab and Cabpirin in Japan
Ophthalmology
Senju Pharmaceutical Co., Ltd. (Japan)

- Co-promotion of Mikeluna combination ophthalmic solution, Mikelan ophthalmic solution, Mikelan LA ophthalmic solution, AIBETA combination ophthalmic solution and AILAMIDE combination ophthalmic suspension in Japan
Diagnostics
Eiken Chemical Co., Ltd. (Japan)

- Co-marketing of RAPIRUN and Uropaper
- Joint research and development of diagnostics
Denka Co., Ltd. (Japan)

- License for Quick Navi series